Common HPLC artifacts and what impurity peaks mean
A non-target peak on an HPLC chromatogram is rarely just "an impurity." It almost always has a specific origin in the synthesis process — and the position, height, and shape of the peak give experienced readers a strong hypothesis about which synthesis step produced it. This article catalogs the common impurity categories, walks through how to distinguish them visually, and separates real impurities from method artifacts. The visual fundamentals are in reading an HPLC chromatogram; the cornerstone framing for what the percentages mean is in what ≥99% purity actually means.
What are the common categories of impurity peak?
Five categories cover the bulk of what shows up on a typical research-peptide chromatogram. Each has a characteristic position relative to the target peak, a characteristic mass shift, and a characteristic abundance pattern.
| Category | Synthesis origin | Retention vs. target | Mass shift |
|---|---|---|---|
| Truncated sequences | Coupling step failed; chain terminated early | Earlier (shorter, more polar) | −1 or more residues |
| Deletion sequences | Coupling failed mid-chain; one residue missing from interior | Close to target (often a shoulder) | −1 residue mass |
| Oxidation products | Met / Trp / Cys oxidized during synthesis or storage | Earlier (more polar) | +16 Da (single oxidation), +32 Da, etc. |
| Deamidation products | Asn / Gln converted to Asp / Glu | Often co-elutes (subtle shift) | +1 Da |
| Residual protecting groups | Protecting group did not fully cleave | Variable, often distinctive | Group-specific (e.g., +Boc, +Fmoc fragments) |
How do you distinguish artifacts from real impurities?
Not every non-target peak is a synthesis-derived impurity. Some peaks come from the HPLC method itself — counter-ions, solvent peaks, system pressure transients — and a complete reading distinguishes them from real impurities of the peptide. The common method-derived artifacts:
- TFA (trifluoroacetic acid) peaks. TFA is used as an ion-pairing modifier in the mobile phase and as a counter-ion in the synthesized peptide. It produces a distinctive UV signature, typically appearing as an early-eluting peak with characteristic absorbance. TFA peaks are method-related, not impurity-related, and they often appear consistently across runs.
- Counter-ion peaks (acetate, formate). Peptides synthesized as acetate or formate salts produce small early-eluting peaks corresponding to the counter-ion. These are part of the salt form, not impurities of the peptide itself.
- System pressure spikes. Sudden pressure changes can produce baseline disturbances that the integration software may flag as peaks. These are visible as sharp deflections without the symmetric peak shape of real chromatographic peaks; they are usually filtered out by setting an integration threshold and are sometimes annotated explicitly in the integration report.
- Air bubbles or injection-volume artifacts. Visible as brief baseline excursions early in the run, often immediately after injection. Reproducible but usually below the integration threshold.
- Solvent-front peaks. The leading edge of the mobile phase carries any non-retained material — buffers, salts, water-soluble impurities — that elutes very early. Often shown as a single packed peak at the chromatogram's start.
A reputable COA distinguishes peptide-derived impurities from method artifacts in the integration table — flagging which peaks are excluded from the purity calculation and which are included. The integration threshold (typically ~0.1% area) handles most artifact noise automatically, but the methodology section should specify both the threshold and any explicitly excluded peaks.
How do you read peak position to guess synthesis origin?
Reverse-phase HPLC separates compounds primarily by hydrophobicity — more hydrophobic compounds interact more strongly with the C18 column and elute later. Synthesis byproducts predictably shift in hydrophobicity from the target, which means their position on the chromatogram tells you what they are.
- Earlier-eluting peaks (left of target): typically more polar than the target. Common origins: truncated sequences (shorter chain length = lower hydrophobicity), oxidation products (introduction of polar oxygen functionality), and deamidation products that have gained negative charge.
- Shoulder peaks on or near the target: typically very close in mass and structure. Common origins: deletion sequences (single-residue mass shift), deamidation (+1 Da), and chiral or sequence isomers that co-elute closely.
- Later-eluting peaks (right of target): typically more hydrophobic. Common origins: residual protecting groups still attached, side-chain modifications that increase hydrophobicity, or higher-mass synthesis byproducts.
Crossing the position-based hypothesis with mass-spectrometry confirmation is what makes the synthesis-origin guess rigorous. The pairing of HPLC and MS is the central reason both methods appear in the three-method release framework — neither alone is sufficient to fully characterize a non-target peak.
When is a shoulder peak structurally different from a separate impurity?
A shoulder peak — a non-baseline-resolved peak immediately adjacent to the target — is one of the most operationally important patterns to recognize. Shoulders typically indicate a co-eluting impurity that the method has not fully resolved: deletion sequences, deamidation products, single-oxidation isoforms, and chiral variants are all common shoulder sources.
A separate impurity peak (baseline-resolved from the target) is fully integrated as its own peak; the integration software cleanly assigns its area and the resulting purity number is reliable. A shoulder peak, in contrast, is partially integrated into the target peak — the calculated purity may overstate the actual content of the intended molecule by the area attributable to the shoulder. Methods that deliberately resolve known shoulders use modified gradients or different columns; the reading an HPLC chromatogram walkthrough covers what to look for visually.
Frequently asked
- What does a peak before the target peak usually represent on a peptide HPLC chromatogram?
- Earlier-eluting peaks are typically more polar than the target — common origins include truncated sequences (shorter chain length means less hydrophobic interaction with the C18 column), oxidation products (polar oxygen functionality), and deamidation products that have gained negative charge. Position alone gives a hypothesis; pairing with mass spectrometry confirms which specific byproduct produced the peak.
- How do I know if a peak on my COA chromatogram is TFA or a real impurity?
- TFA peaks have characteristic UV absorbance signatures and typically appear as early-eluting peaks with consistent retention across runs. Reputable analytical labs annotate or exclude them from purity calculations explicitly — the integration table should clarify which peaks are method-related artifacts and which are peptide-derived impurities. If the integration table doesn't distinguish them, ask the vendor or the lab for clarification.
- What is a shoulder peak and why does it matter?
- A shoulder peak is a non-baseline-resolved peak immediately adjacent to the target — visually a "shoulder" rising off the side of the dominant peak rather than appearing as a separate peak with clean baseline between them. Shoulders typically indicate co-eluting impurities (deletion sequences, deamidation products, single-oxidation isoforms) that the method has not fully resolved. Because shoulders are partially integrated into the target peak, the reported purity may overstate the content of the intended molecule.
- Are oxidation products always a problem on a peptide COA?
- They are characteristic of synthesis or storage conditions that allowed oxidation to occur, but their consequence depends on the abundance and the research application. Trace oxidation (resolvable peaks summing to under 0.5%) is normal for peptides with methionine, tryptophan, or cysteine residues and is unlikely to compromise most research uses. Higher oxidation loads — particularly visible as resolved peaks above 1% — suggest the batch was synthesized or stored under conditions that warrant attention.
- How can I tell deletion sequences apart from the target peak?
- On HPLC alone, often you cannot — deletion sequences (peptides missing one residue from the middle of the chain) typically have similar retention times to the target and frequently co-elute as shoulders. The reliable distinguisher is mass spectrometry: a deletion sequence appears as a separate ion at the target mass minus the mass of the missing residue. This is one of the central reasons HPLC and mass spec are paired rather than used alone.
Sources and further reading
- USP <621> Chromatography — system suitability requirements and reporting standards including peak resolution and integration practice.
- USP <1086> Impurities in Drug Substances and Drug Products — guidance on classifying and reporting impurity peaks observed in chromatographic analysis.
- Snyder, Kirkland, & Dolan — Introduction to Modern Liquid Chromatography (Wiley, 3rd ed.) — the standard graduate-level reference on HPLC method development and chromatogram interpretation.